Clinical Trials
latest news & developments#Aids2026: Daily pill. Monthly pill. Six-monthly jab. Why choice matters
For the first time, Merck has granted generic manufacturers, including three African companies, permission to produce an investigational monthly HIV prevention pill, alimatravir,…
The US’s NIH funds R6.65 billion of research in South Africa
If all of its National Institutes of Health funding falls away, the country could lose 70% of its medical research capacity
Trump ends SA’s HIV and TB research grants
Cancellation letters, which end millions of rands of South African universities’ US-government funded HIV and TB research grants with immediate effect, started to roll in over…
More malaria vaccines in the pipeline
Researchers are calling for more partnerships and funding for malaria programmes, while 2.3-million children in three African countries have already received a jab
Lowdown on Pfizer’s Covid vaccine
The recent announcement of a promising Covid-19 vaccine is good news. But don’t get too excited, cautions Simon Allison: other more affluent countries have already bought up most…
Q&A Sessions: ‘My north star is the patient’
Rhulani Nhlaniki is Pfizer’s cluster lead for sub-Saharan Africa. As Pfizer starts phase III of the clinical trial of their Covid-19 vaccine candidate, he tells Malaikah Bophela…
My late uncle, and the ethics of clinical trials in Africa
Despite the long history of medical racism, any potential Covid-19 vaccines must be tested in Africa — but not only on the continent
Unique Charlotte Maxeke hospital ward faces closure
It is a beacon of hope, yet the state’s cystic fibrosis unit at the Charlotte Maxeke Johannesburg Academic Hospital might be closed.
There’s solace in numbers in the world of rare diseases
It’s been a long journey of discovery for the family of a Cape Town girl who suffers from cystinosis.
ME study reveals benefits of exercise
But some patient groups denounced the trial in its entirety.
Medicines body in poor state, says DA
A clinical trial which could benefit Aids patients is about to lose its funding because the Medicines Control Council won’t answer its phones.